CCAAT/enhancer-binding protein β: Its role in breast cancer and associations with receptor tyrosine kinases

Expert Reviews in Molecular Medicine

Volumn 11, Issue , 2009, Pages

  Zahnow, Cynthia A ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN; PROTEIN TYROSINE KINASE;

BREAST TUMOR; FEMALE; HUMAN; METABOLISM; PHYSIOLOGY; PROTEIN PROCESSING; REVIEW;

BREAST NEOPLASMS; CCAAT-ENHANCER-BINDING PROTEINS; FEMALE; HUMANS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTOR PROTEIN-TYROSINE KINASES;

EID: 65349107367     PISSN: 14623994     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1462399409001033     Document Type: Review

References (201)

1. Cao, Z., Umek, R.M. and McKnight, S.L. (1991) Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes and Development 5, 1538-1552 (Pubitemid 21906060)
2. Diehl, A.M. (1998) Roles of CCAAT/enhancer-binding proteins in regulation of liver regenerative growth. Journal of Biological Chemistry 273, 30843-30846
3. Poli, V. (1998) The role of C/EBP isoforms in the control of inflammatory and native immunity functions. Journal of Biological Chemistry 273, 29279-29282
4. Zahnow, C.A. (2002) CCAAT/enhancer binding proteins in normal mammary development and breast cancer. Breast Cancer Research 4, 113-121
5. Ramji, D.P. and Foka, P. (2002) CCAAT/enhancerbinding proteins: structure, function and regulation. Biochemical Journal 365, 561-575 (Pubitemid 34864439)
6. Sebastian, T. and Johnson, P.F. (2006) Stop and go: anti-proliferative and mitogenic functions of the transcription factor C/EBPbeta. Cell Cycle 5, 953-957
7. Kowenz-Leutz, E. et al. (1994) Novel mechanism of C/EBP beta (NF-M) transcriptional control: activation through derepression. Genes and Development 8, 2781-2791 (Pubitemid 24375426)
8. Williams, S.C. et al. (1995) CRP2 (C/EBP beta) contains a bipartite regulatory domain that controls transcriptional activation, DNA binding and cell specificity. EMBO Journal 14, 3170-3183
9. Angerer, N.D. et al. (1999) A short conserved motif is required for repressor domain function in the myeloid-specific transcription factor CCAAT/ enhancer-binding protein epsilon. Journal of Biological Chemistry 274, 4147-4154
10. Williamson, E.A. et al. (1998) Identification of transcriptional activation and repression domains in human CCAAT/enhancer-binding protein epsilon. Journal of Biological Chemistry 273, 14796-14804 (Pubitemid 28272766)
11. Mink, S., Haenig, B. and Klempnauer, K.H. (1997) Interaction and functional collaboration of p300 and C/EBPbeta. Molecular and Cellular Biology 17, 6609-6617 (Pubitemid 27451207)
12. Nerlov, C. and Ziff, E.B. (1995) CCAAT/ enhancer binding protein-alpha amino acid motifs with dual TBP and TFIIB binding ability co-operate to activate transcription in both yeast and mammalian cells. EMBO Journal 14, 4318-4328
13. Graves, B.J., Johnson, P.F. and McKnight, S.L. (1986) Homologous recognition of a promoter domain common to the MSV LTR and the HSV tk gene. Cell 44, 565-576 (Pubitemid 16083697)
14. Johnson, P.F. et al. (1987) Identification of a rat liver nuclear protein that binds to the enhancer core element of three animal viruses. Genes and Development 1, 133-146
15. Landschulz, W.H. et al. (1988) Isolation of a recombinant copy of the gene encoding C/EBP. Genes and Development 2, 786-800
16. Descombes, P. et al. (1990) LAP, a novel member of the C/EBP gene family, encodes a liver-enriched transcriptional activator protein. Genes and Development 4, 1541-1551
17. Chang, C.J. et al. (1990) Molecular cloning of a transcription factor, AGP/EBP, that belongs to members of the C/EBP family. Molecular and Cellular Biology 10, 6642-6653
18. Akira, S. et al. (1990) A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. EMBO Journal 9, 1897-1906
19. Poli, V., Mancini, F.P. and Cortese, R. (1990) IL-6DBP, a nuclear protein involved in interleukin-6 signal transduction, defines a new family of leucine zipper proteins related to C/EBP. Cell 63, 643-653
20. Descombes, P. and Schibler, U. (1991) A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA. Cell 67, 569-579 (Pubitemid 121001471)
21. Ossipow, V., Descombes, P. and Schibler, U. (1993) CCAAT/enhancer-binding protein mRNA is translated into multiple proteins with different transcription activation potentials. Proceedings of the National Academy of Sciences of the United States of America 90, 8219-8223 (Pubitemid 23260887)
22. Calkhoven, C.F., Muller, C. and Leutz, A. (2000) Translational control of C/EBPalpha and C/EBPbeta isoform expression. Genes and Development 14, 1920-1932 (Pubitemid 30639525)
23. Xiong, W. et al. (2001) Regulation of CCAAT/ enhancer-binding protein-beta isoform synthesis by alternative translational initiation at multiple AUG start sites. Nucleic Acids Research 29, 3087-3098 (Pubitemid 32685235)
24. Lin, F.T. et al. (1993) A 30-kDa alternative translation product of the CCAAT/enhancer binding protein alpha message: transcriptional activator lacking antimitotic activity. Proceedings of the National Academy of Sciences of the United States of America 90, 9606-9610
25. Welm, A.L., Timchenko, N.A. and Darlington, G.J. (1999) C/EBPalpha regulates generation of C/EBPbeta isoforms through activation of specific proteolytic cleavage. Molecular and Cellular Biology 19, 1695-1704 (Pubitemid 29098228)
26. Yamanaka, R. et al. (1997) CCAAT/enhancer binding protein epsilon is preferentially upregulated during granulocytic differentiation and its functional versatility is determined by alternative use of promoters and differential splicing. Proceedings of the National Academy of Sciences of the United States of America 94, 6462-6467
27. Vinson, C.R., Sigler, P.B. and McKnight, S.L. (1989) Scissors-grip model for DNA recognition by a family of leucine zipper proteins. Science 246, 911-916 (Pubitemid 20010501)
28. Agre, P., Johnson, P.F. and McKnight, S.L. (1989) Cognate DNA binding specificity retained after leucine zipper exchange between GCN4 and C/EBP. Science 246, 922-926 (Pubitemid 20010504)
29. Moll, J.R. et al. (2002) Magnesium is required for specific DNA binding of the CREB B-ZIP domain. Nucleic Acids Research 30, 1240-1246 (Pubitemid 34679698)
30. Osada, S. et al. (1996) DNA binding specificity of the CCAAT/enhancer-binding protein transcription factor family. Journal of Biological Chemistry 271, 3891-3896 (Pubitemid 26065711)
31. Ron, D. and Habener, J.F. (1992) CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant-negative inhibitor of gene transcription. Genes and Development 6, 439-453
32. Ubeda, M. et al. (1996) Stress-induced binding of the transcriptional factor CHOP to a novel DNA control element. Molecular and Cellular Biology 16, 1479-1489 (Pubitemid 26095618)
33. Cooper, C. et al. (1995) Ig/EBP (C/EBP gamma) is a transdominant negative inhibitor of C/EBP family transcriptional activators. Nucleic Acids Research 23, 4371-4377
34. Lekstrom-Himes, J.A. (2001) The role of C/ EBP(epsilon) in the terminal stages of granulocyte differentiation. Stem Cells 19, 125-133
35. Grimm, S.L. and Rosen, J.M. (2003) The role of C/ EBPbeta in mammary gland development and breast cancer. Journal of Mammary Gland Biology and Neoplasia 8, 191-204 (Pubitemid 38129941)
36. Vinson, C. et al. (2002) Classification of human BZIP proteins based on dimerization properties. Molecular and Cellular Biology 22, 6321-6335
37. Takiguchi, M. (1998) The C/EBP family of transcription factors in the liver and other organs. International Journal of Experimental Pathology 79, 369-391
38. Nakajima, T. et al. (1993) Phosphorylation at threonine-235 by a ras-dependent mitogenactivated protein kinase cascade is essential for transcription factor NF-IL6. Proceedings of the National Academy of Sciences of the United States of America 90, 2207-2211 (Pubitemid 23078595)
39. Zhu, S. et al. (2002) CCAAT/enhancer binding protein-beta is a mediator of keratinocyte survival and skin tumorigenesis involving oncogenic Ras signaling. Proceedings of the National Academy of Sciences of the United States of America 99, 207-212 (Pubitemid 34060342)
40. Mo, X. et al. (2004) Ras induces mediator complex exchange on C/EBP beta. Molecular Cell 13, 241-250 (Pubitemid 38183270)
41. Liao, J. et al. (1999) CCAAT/enhancer-binding protein beta (C/EBPbeta) and C/EBPdelta contribute to growth hormone-regulated transcription of c-fos. Journal of Biological Chemistry 274, 31597-31604
42. Piwien-Pilipuk, G. et al. (2001) Growth hormone regulates phosphorylation and function of CCAAT/enhancer-binding protein beta by modulating Akt and glycogen synthase kinase-3. Journal of Biological Chemistry 276, 19664-19671
43. Tang, Q.Q. et al. (2005) Sequential phosphorylation of CCAAT enhancer-binding protein beta by MAPK and glycogen synthase kinase 3beta is required for adipogenesis. Proceedings of the National Academy of Sciences of the United States of America 102, 9766-9771
44. Wegner, M., Cao, Z. and Rosenfeld, M.G. (1992) Calcium-regulated phosphorylation within the leucine zipper of C/EBP beta. Science 256, 370-373
45. Buck, M. et al. (1999) Phosphorylation of rat serine 105 or mouse threonine 217 in C/EBP beta is required for hepatocyte proliferation induced by TGF alpha. Molecular Cell 4, 1087-1092
46. Buck, M. et al. (2001) C/EBPbeta phosphorylation by RSK creates a functional XEXD caspase inhibitory box critical for cell survival. Molecular Cell 8, 807-816 (Pubitemid 33030214)
47. Metz, R. and Ziff, E. (1991) cAMP stimulates the C/ EBP-related transcription factor rNFIL-6 to trans-locate to the nucleus and induce c-fos transcription. Genes and Development 5, 1754-1766 (Pubitemid 121000007)
48. Trautwein, C. et al. (1993) Transactivation by NFIL6/ LAP is enhanced by phosphorylation of its activation domain. Nature 364, 544-547 (Pubitemid 23273102)
49. Trautwein, C. et al. (1994) Protein kinase A and C site-specific phosphorylations of LAP (NF-IL6) modulate its binding affinity to DNA recognition elements. Journal of Clinical Investigation 93, 2554-2561 (Pubitemid 24177171)
50. Mahoney, C.W. et al. (1992) Phosphorylation of CCAAT-enhancer binding protein by protein kinase C attenuates site-selective DNA binding. Journal of Biological Chemistry 267, 19396-19403
51. Chinery, R. et al. (1997) Antioxidant-induced nuclear translocation of CCAAT/enhancerbinding protein beta. A critical role for protein kinase A-mediated phosphorylation of Ser299. Journal of Biological Chemistry 272, 30356-30361 (Pubitemid 27512244)
52. Shuman, J.D. et al. (2004) Cell cycle-dependent phosphorylation of C/EBPbeta mediates oncogenic cooperativity between C/EBPbeta and H-RasV12. Molecular and Cellular Biology 24, 7380-7391 (Pubitemid 39121468)
53. Cesena, T.I. et al. (2007) CCAAT/enhancer-binding protein (C/EBP) beta is acetylated at multiple lysines: acetylation of C/EBPbeta at lysine 39 modulates its ability to activate transcription. Journal of Biological Chemistry 282, 956-967 (Pubitemid 47076527)
54. Cesena, T.I. et al. (2008) Acetylation and deacetylation regulate CCAAT/enhancer binding protein beta at K39 in mediating gene transcription. Molecular and Cellular Endocrinology 289, 94-101
55. Wiper-Bergeron, N. et al. (2007) Glucocorticoidstimulated preadipocyte differentiation is mediated through acetylation of C/EBPbeta by GCN5. Proceedings of the National Academy of Sciences of the United States of America 104, 2703-2708 (Pubitemid 46327943)
56. Xu, M. et al. (2003) STAT5-induced Id-1 transcription involves recruitment of HDAC1 and deacetylation of C/EBPbeta. EMBO Journal 22, 893-904 (Pubitemid 36227791)
57. Pless, O. et al. (2008) G9a-mediated lysine methylation alters the function of CCAAT/ enhancer-binding protein-beta. Journal of Biological Chemistry 283, 26357-26363
58. Melchior, F. (2000) SUMO-nonclassical ubiquitin. Annual Review of Cell and Developmental Biology 16, 591-626
59. Eaton, E.M. and Sealy, L. (2003) Modification of CCAAT/enhancer-binding protein-beta by the small ubiquitin-like modifier (SUMO) family members, SUMO-2 and SUMO-3. Journal of Biological Chemistry 278, 33416-33421 (Pubitemid 37055795)
60. Berberich-Siebelt, F. et al. (2006) SUMOylation interferes with CCAAT/enhancer-binding protein beta-mediated c-myc repression, but not IL-4 activation in T cells. Journal of Immunology 176, 4843-4851
61. Kowenz-Leutz, E. and Leutz, A. (1999) A C/ EBP beta isoform recruits the SWI/SNF complex to activate myeloid genes. Molecular Cell 4, 735-743
62. Ness, S.A. et al. (1993) Myb and NF-M: combinatorial activators of myeloid genes in heterologous cell types. Genes and Development 7, 749-759 (Pubitemid 23163580)
63. Burk, O. et al. (1993) Synergistic activation of the chicken mim-1 gene by v-myb and C/ EBP transcription factors. EMBO Journal 12, 2027-2038 (Pubitemid 23157719)
64. Su,W.C. et al. (2003) Differential activation of a C/ EBP beta isoform by a novel redox switch may confer the lipopolysaccharide-inducible expression of interleukin-6 gene. Journal of Biological Chemistry 278, 51150-51158
65. Qiu, X. et al. (2008) Distinct functions of CCAAT enhancer-binding protein isoforms in the regulation of manganese superoxide dismutase during interleukin-1beta stimulation. Journal of Biological Chemistry 283, 25774-25785
66. Eaton, E.M. et al. (2001) Characterization of C/ EBPbeta isoforms in normal versus neoplastic mammary epithelial cells. Journal of Cellular Physiology 189, 91-105
67. Ishiguro, K. and Xavier, R. (2004) Homer-3 regulates activation of serum response element in T cells via its EVH1 domain. Blood 103, 2248-2256 (Pubitemid 38326244)
68. Lee, Y.M. et al. (1996) Transcriptional induction of the alpha-1 acid glycoprotein (AGP) gene by synergistic interaction of two alternative activator forms of AGP/enhancer-binding protein (C/EBPbeta) and NF-kappaB or Nopp140. Molecular and Cellular Biology 16, 4257-4263
69. Zahnow, C.A. et al. (2001) A role for CCAAT/ enhancer binding protein beta-liver-enriched inhibitory protein in mammary epithelial cell proliferation. Cancer Research 61, 261-269 (Pubitemid 32095726)
70. Harrison, J.R. et al. (2005) Col1a1 promotertargeted expression of p20 CCAAT enhancerbinding protein beta (C/EBPbeta), a truncated C/EBPbeta isoform, causes osteopenia in transgenic mice. Journal of Biological Chemistry 280, 8117-8124 (Pubitemid 40349711)
71. Savage, T. et al. (2006) Mandibular phenotype of p20C/EBPbeta transgenic mice: Reduced alveolar bone mass and site-specific dentin dysplasia. Bone 39, 552-564 (Pubitemid 44149271)
72. An, M.R. et al. (1996) Evidence for posttranscriptional regulation of C/EBPalpha and C/EBPbeta isoform expression during the lipopolysaccharide- mediated acute-phase response. Molecular and Cellular Biology 16, 2295-2306 (Pubitemid 26123750)
73. Williams, P. et al. (1991) AGP/EBP(LAP) expressed in rat hepatoma cells interacts with multiple promoter sites and is necessary for maximal glucocorticoid induction of the rat alpha-1 acid glycoprotein gene. Molecular and Cellular Biology 11, 4959-4965 (Pubitemid 21895257)
74. Ratajczak, T. et al. (1992) Multiple elements within the glucocorticoid regulatory unit of the rat alpha 1-acid glycoprotein gene are recognition sites for C/EBP. Journal of Biological Chemistry 267, 11111-11119
75. Nishio, Y. et al. (1993) A nuclear factor for interleukin-6 expression (NF-IL6) and the glucocorticoid receptor synergistically activate transcription of the rat alpha 1-acid glycoprotein gene via direct protein-protein interaction. Molecular and Cellular Biology 13, 1854-1862
76. Isshiki, H. et al. (1990) Constitutive and interleukin-1 (IL-1)-inducible factors interact with the IL-1-responsive element in the IL-6 gene. Molecular and Cellular Biology 10, 2757-2764
77. Hu, H.M. et al. (2000) The C/EBP bZIP domain can mediate lipopolysaccharide induction of the proinflammatory cytokines interleukin-6 and monocyte chemoattractant protein-1. Journal of Biological Chemistry 275, 16373-16381
78. Matsusaka, T. et al. (1993) Transcription factors NFIL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proceedings of the National Academy of Sciences of the United States of America 90, 10193-10197 (Pubitemid 23328278)
79. Stein, B., Cogswell, P.C. and Baldwin, A.S. Jr. (1993) Functional and physical associations between NFkappa B and C/EBP family members: a Rel domain-bZIP interaction. Molecular and Cellular Biology 13, 3964-3974 (Pubitemid 23187624)
80. Christian, M. et al. (2002) Functional association of PR and CCAAT/enhancer-binding protein beta isoforms: promoter-dependent cooperation between PR-B and liver-enriched inhibitory protein, or liver-enriched activatory protein and PR-A in human endometrial stromal cells. Molecular Endocrinology 16, 141-154 (Pubitemid 34044504)
81. Kalkhoven, E. et al. (1996) Negative interaction between the RelA(p65) subunit of NF-kappaB and the progesterone receptor. Journal of Biological Chemistry 271, 6217-6224 (Pubitemid 26095429)
82. Hata, K. et al. (2005) A CCAAT/enhancer binding protein beta isoform, liver-enriched inhibitory protein, regulates commitment of osteoblasts and adipocytes. Molecular and Cellular Biology 25, 1971-1979 (Pubitemid 40280159)
83. Tang, Q.Q., Otto, T.C. and Lane, M.D. (2003) CCAAT/enhancer-binding protein beta is required for mitotic clonal expansion during adipogenesis. Proceedings of the National Academy of Sciences of the United States of America 100, 850-855 (Pubitemid 36183919)
84. Vegesna, V. et al. (2002) C/EBP-beta, C/EBP-delta, PU.1, AML1 genes: mutational analysis in 381 samples of hematopoietic and solid malignancies. Leukemia Research 26, 451-457 (Pubitemid 34251089)
85. Mastracci, T.L. et al. (2006) Genomic alterations in lobular neoplasia: a microarray comparative genomic hybridization signature for early neoplastic proliferationin the breast. Genes, Chromosomes and Cancer 45, 1007-1017 (Pubitemid 44435535)
86. Rhodes, D.R. et al. (2004) ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia 6, 1-6 (Pubitemid 38391943)
87. Alaoui-Jamali, M.A. et al. (2003) Regulation of multiple tumor microenvironment markers by overexpression of single or paired combinations of ErbB receptors. Cancer Research 63, 3764-3774
88. van't Veer, L.J. et al. (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415, 530-536
89. Gruvberger, S. et al. (2001) Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. Cancer Research 61, 5979-5984 (Pubitemid 32762524)
90. van de Vijver, M.J. et al. (2002) A gene-expression signature as a predictor of survival in breast cancer. New England Journal of Medicine 347, 1999-2009
91. Yang, F. et al. (2006) Laser microdissection and microarray analysis of breast tumors reveal ERalpha related genes and pathways. Oncogene 25, 1413-1419 (Pubitemid 43336470)
92. Saal, L.H. et al. (2007) Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity. Proceedings of the National Academy of Sciences of the United States of America 104, 7564-7569 (Pubitemid 47185946)
93. Finak, G. et al. (2008) Stromal gene expression predicts clinical outcome in breast cancer. Nature Medicine 14, 518-527 (Pubitemid 351655218)
94. Ma, X.J. et al. (2004) A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen. Cancer Cell 5, 607-616
95. Zahnow, C.A. et al. (1997) Overexpression of C/ EBPbeta-LIP, a naturally occurring, dominantnegative transcription factor, in human breast cancer. Journal of the National Cancer Institute 89, 1887-1891 (Pubitemid 28009825)
96. Milde-Langosch, K., Loning, T. and Bamberger, A.M. (2003) Expression of the CCAAT/enhancerbinding proteins C/EBPalpha, C/EBPbeta and C/ EBPdelta in breast cancer: correlations with clinicopathologic parameters and cell-cycle regulatory proteins. Breast Cancer Research and Treatment 79, 175-185 (Pubitemid 36649167)
97. Gomis, R.R. et al. (2006) C/EBPbeta at the core of the TGFbeta cytostatic response and its evasion in metastatic breast cancer cells. Cancer Cell 10, 203-214 (Pubitemid 44311064)
98. Seagroves, T.N. et al. (1998) C/EBPbeta, but not C/EBPalpha, is essential for ductal morphogenesis, lobuloalveolar proliferation, and functional differentiation in the mouse mammary gland. Genes and Development 12, 1917-1928 (Pubitemid 28304343)
99. Robinson, G.W. et al. (1998) The C/EBPbeta transcription factor regulates epithelial cell proliferation and differentiation in the mammary gland. Genes and Development 12, 1907-1916 (Pubitemid 28304342)
100. Seagroves, T.N. et al. (2000) C/EBPbeta (CCAAT/ enhancer binding protein) controls cell fate determination during mammary gland development. Molecular Endocrinology 14, 359-368 (Pubitemid 32260528)
101. Uematsu, S. et al. (2007) The C/EBP beta isoform 34-kDa LAP is responsible for NF-IL-6-mediated gene induction in activated macrophages, but is not essential for intracellular bacteria killing. Journal of Immunology 179, 5378-5386
102. Baldwin, B.R., Timchenko, N.A. and Zahnow, C.A. (2004) Epidermal Growth Factor Receptor Stimulation Activates the RNA Binding Protein CUG-BP1 and Increases Expression of C/EBPbeta- LIP in Mammary Epithelial Cells. Molecular and Cellular Biology 24, 3682-3691 (Pubitemid 38496148)
103. Bundy, L.M. and Sealy, L. (2003)CCAAT/enhancer binding protein beta (C/EBPbeta)-2 transforms normal mammary epithelial cells and induces epithelial to mesenchymal transition in culture. Oncogene 22, 869-883 (Pubitemid 36255823)
104. Zhou, J. et al. (2001) Malignant breast epithelial cells stimulate aromatase expression via promoter II in human adipose fibroblasts: an epithelialstromal interaction in breast tumors mediated by CCAAT/enhancer binding protein beta. Cancer Research 61, 2328-2334 (Pubitemid 32692067)
105. Combates, N.J. et al. (1994) NF-IL6, a member of the C/EBP family of transcription factors, binds and trans-activates the human MDR1 gene promoter. Journal of Biological Chemistry 269, 29715-29719 (Pubitemid 24365130)
106. Conze, D. et al. (2001) Autocrine production of interleukin 6 causes multidrug resistance in breast cancer cells. Cancer Research 61, 8851-8858 (Pubitemid 34013900)
107. Chen, G.K. et al. (2004) CCAAT/enhancer-binding protein beta (nuclear factor for interleukin 6) transactivates the human MDR1 gene by interaction with an inverted CCAAT box in human cancer cells. Molecular Pharmacology 65, 906-916 (Pubitemid 38420496)
108. Leonessa, F. and Clarke, R. (2003) ATP binding cassette transporters and drug resistance in breast cancer. Endocrine-Related Cancer 10, 43-73 (Pubitemid 36457239)
109. Wessells, J., Yakar, S. and Johnson, P.F. (2004) Critical prosurvival roles for C/EBP beta and insulin-like growth factor I in macrophage tumor cells. Molecular and Cellular Biology 24, 3238-3250 (Pubitemid 38452069)
110. Yoon, K. et al. (2007) Decreased survival of C/EBP beta-deficient keratinocytes is due to aberrant regulation of p53 levels and function. Oncogene 26, 360-367 (Pubitemid 46122826)
111. Ewing, S.J. et al. (2008) C/EBPbeta represses p53 to promote cell survival downstream of DNA damage independent of oncogenic Ras and p19(Arf). Cell Death and Differentiation 15, 1734-1744
112. Buck, M., Turler, H. and Chojkier, M. (1994) LAP (NF-IL-6), a tissue-specific transcriptional activator, is an inhibitor of hepatoma cell proliferation. EMBO Journal 13, 851-860 (Pubitemid 24057516)
113. Zhu, S. et al. (1999) C/EBPbeta modulates the early events of keratinocyte differentiation involving growth arrest and keratin 1 and keratin 10 expression. Molecular and Cellular Biology 19, 7181-7190 (Pubitemid 29441898)
114. Johnson, P.F. (2005) Molecular stop signs: regulation of cell-cycle arrest by C/EBP transcription factors. Journal of Cell Science 118, 2545-2555
115. Sebastian, T. et al. (2005) C/EBPbeta cooperates with RB:E2F to implement Ras(V12)-induced cellular senescence. EMBO Journal 24, 3301-3312 (Pubitemid 41348704)
116. Acosta, J.C. et al. (2008) Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell 133, 1006-1018
117. Kuilman, T. et al. (2008) Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell 133, 1019-1031 (Pubitemid 351787746)
118. Schlessinger, J. (2002) Ligand-induced, receptormediated dimerization and activation of EGF receptor. Cell 110, 669-672
119. Hynes, N.E. and Lane, H.A. (2005) ERBB receptors and cancer: the complexity of targeted inhibitors. Nature Reviews. Cancer 5, 341-354 (Pubitemid 40637826)
120. Zahnow, C.A. (2006) ErbB receptors and their ligands in the breast. Expert Rev Molecular Medicine 8, 1-21
121. Walker, R.A. and Dearing, S.J. (1999) Expression of epidermal growth factor receptor mRNA and protein in primary breast carcinomas. Breast Cancer Research and Treatment 53, 167-176 (Pubitemid 29161123)
122. Di Fiore, P.P. et al. (1987) erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells. Science 237, 178-182 (Pubitemid 17095921)
123. Allred, D.C. et al. (1992)Overexpression of HER-2/ neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer. Human Pathology 23, 974-979
124. Arcidiacono, M.V. et al. (2008) EGFR activation increases parathyroid hyperplasia and calcitriol resistance in kidney disease. Journal of the American Society of Nephrology 19, 310-320 (Pubitemid 351240653)
125. He, D. et al. (2008) Lysophosphatidic acid-induced transactivation of epidermal growth factor receptor regulates cyclo-oxygenase-2 expression and prostaglandin E(2) release via C/EBPbeta in human bronchial epithelial cells. Biochemical Journal 412, 153-162 (Pubitemid 351678345)
126. Dickson, C. et al. (2000) Tyrosine kinase signalling in breast cancer: fibroblast growth factors and their receptors. Breast Cancer Research 2, 191-196 (Pubitemid 32223584)
127. Eswarakumar, V.P., Lax, I. and Schlessinger, J. (2005) Cellular signaling by fibroblast growth factor receptors. Cytokine and Growth Factor Reviews 16, 139-149 (Pubitemid 40616112)
128. Klagsbrun, M. and Baird, A. (1991)Adual receptor systemis required for basic fibroblast growth factor activity. Cell 67, 229-231 (Pubitemid 121001439)
129. Tsukamoto, A.S. et al. (1988) Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice. Cell 55, 619-625
130. Welm, B.E. et al. (2002) Inducible dimerization of FGFR1: development of a mouse model to analyze progressive transformation of the mammary gland. Journal of Cell Biology 157, 703-714 (Pubitemid 34839797)
131. Penault-Llorca, F. et al. (1995) Expression of FGF and FGF receptor genes in human breast cancer. International Journal of Cancer 61, 170-176
132. Zammit, C. et al. (2002) Fibroblast growth factor 8 is expressed at higher levels in lactating human breast and in breast cancer. British Journal of Cancer 86, 1097-1103 (Pubitemid 34438081)
133. Tamaru, N. et al. (2004) Estrogen receptorassociated expression of keratinocyte growth factor and its possible role in the inhibition of apoptosis in human breast cancer. Laboratory Investigation 84, 1460-1471 (Pubitemid 39482163)
134. Theodorou, V. et al. (2004) Fgf10 is an oncogene activated by MMTV insertional mutagenesis in mouse mammary tumors and overexpressed in a subset of human breast carcinomas. Oncogene 23, 6047-6055 (Pubitemid 39178857)
135. Reis-Filho, J.S. et al. (2006) FGFR1 emerges as a potential therapeutic target for lobular breast carcinomas. Clinical Cancer Research 12, 6652-6662 (Pubitemid 44876833)
136. Meijer, D. et al. (2008) Fibroblast growth factor receptor 4 predicts failure on tamoxifen therapy in patients with recurrent breast cancer. Endocrine- Related Cancer 15, 101-111 (Pubitemid 351449731)
137. Luqmani, Y.A., Graham, M. and Coombes, R.C. (1992) Expression of basic fibroblast growth factor, FGFR1 and FGFR2 in normal and malignant human breast, and comparison with other normal tissues. British Journal of Cancer 66, 273-280
138. Hunter, D.J. et al. (2007) A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nature Genetics 39, 870-874 (Pubitemid 47014500)
139. Easton, D.F. et al. (2007) Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447, 1087-1093
140. Meyer, K.B. et al. (2008) Allele-specific upregulation of FGFR2 increases susceptibility to breast cancer. PLoS Biology 6, e108
141. Kagan, B.L. et al. (2003) Complex regulation of the fibroblast growth factor-binding protein in MDAMB-468 breast cancer cells by CCAAT/enhancerbinding protein beta. Cancer Research 63, 1696-1705 (Pubitemid 36373663)
142. Czubayko, F. et al. (1994) Tumor growth and angiogenesis induced by a secreted binding protein for fibroblast growth factors. Journal of Biological Chemistry 269, 28243-28248 (Pubitemid 24354563)
143. Papa, V. et al. (1990) Elevated insulin receptor content in human breast cancer. Journal of Clinical Investigation 86, 1503-1510 (Pubitemid 20372597)
144. Holdaway, I.M. and Friesen, H.G. (1977) Hormone binding by human mammary carcinoma. Cancer Research 37, 1946-1952
145. Milazzo, G. et al. (1992) Insulin receptor expression and function in human breast cancer cell lines. Cancer Research 52, 3924-3930
146. Finlayson, C.A. et al. (2003) Enhanced insulin signaling via Shc in human breast cancer. Metabolism 52, 1606-1611 (Pubitemid 38049280)
147. Pekonen, F. et al. (1988) Receptors for epidermal growth factor and insulin-like growth factor I and their relation to steroid receptors in human breast cancer. Cancer Research 48, 1343-1347 (Pubitemid 18075556)
148. Foekens, J.A. et al. (1989) Prognostic value of receptors for insulin-like growth factor 1, somatostatin, and epidermal growth factor in human breast cancer. Cancer Research 49, 7002-7009 (Pubitemid 20016583)
149. Bonneterre, J. et al. (1990) Prognostic significance of insulin-like growth factor 1 receptors in human breast cancer. Cancer Research 50, 6931-6935 (Pubitemid 20361093)
150. Surmacz, E. (2000) Function of the IGF-I receptor in breast cancer. Journal of Mammary Gland Biology and Neoplasia 5, 95-105
151. Goodwin, P.J. et al. (2002) Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. Journal of Clinical Oncology 20, 42-51 (Pubitemid 34032594)
152. Pasanisi, P. et al. (2006) Metabolic syndrome as a prognostic factor for breast cancer recurrences. International Journal of Cancer 119, 236-238
153. Pasanisi, P. et al. (2008) Serum insulin-like growth factor-I and platelet-derived growth factor as biomarkers of breast cancer prognosis. Cancer Epidemiology Biomarkers & Prevention 17, 1719-1722
154. Papa, V., Costantino, A. and Belfiore, A. (1997) Insulin receptor what role in breast cancer? Trends in Endocrinology and Metabolism 8, 306-312 (Pubitemid 27516732)
155. Lu, M., Seufert, J. and Habener, J.F. (1997) Pancreatic beta-cell-specific repression of insulin gene transcription by CCAAT/enhancer-binding protein beta. Inhibitory interactions with basic helix-loop-helix transcription factor E47. Journal of Biological Chemistry 272, 28349-28359 (Pubitemid 27517780)
156. Seufert, J., Weir, G.C. and Habener, J.F. (1998) Differential expression of the insulin gene transcriptional repressor CCAAT/enhancerbinding protein beta and transactivator islet duodenum homeobox-1 in rat pancreatic beta cells during the development of diabetes mellitus. Journal of Clinical Investigation 101, 2528-2539 (Pubitemid 28270447)
157. Shen, C.N. et al. (2003) Glucocorticoids suppress beta-cell development and induce hepatic metaplasia in embryonic pancreas. Biochemical Journal 375, 41-50
158. Wang, L. et al. (2000) Increased insulin receptor substrate-1 and enhanced skeletal muscle insulin sensitivity in mice lacking CCAAT/enhancerbinding protein beta. Journal of Biological Chemistry 275, 14173-14181 (Pubitemid 30339694)
159. Foti, D. et al. (2003) A nucleoprotein complex containing Sp1, C/EBP beta, and HMGI-Y controls human insulin receptor gene transcription. Molecular and Cellular Biology 23, 2720-2732 (Pubitemid 36403073)
160. MacDougald, O.A. et al. (1995) Insulin regulates transcription of the CCAAT/enhancer binding protein (C/EBP) alpha, beta, and delta genes in fully-differentiated 3T3-L1 adipocytes. Journal of Biological Chemistry 270, 647-654
161. Le Lay, S. et al. (2002) Insulin and sterol-regulatory element-binding protein-1c (SREBP-1C) regulation of gene expression in 3T3-L1 adipocytes. Identification of CCAAT/enhancer-binding protein beta as an SREBP-1C target. Journal of Biological Chemistry 277, 35625-35634
162. Duong, D.T. et al. (2002) Insulin inhibits hepatocellular glucose production by utilizing liver-enriched transcriptional inhibitory protein to disrupt the association of CREB-binding protein and RNA polymerase II with the phosphoenolpyruvate carboxykinase gene promoter. Journal of Biological Chemistry 277, 32234-32242 (Pubitemid 34969039)
163. Bosch, F., Sabater, J. and Valera, A. (1995) Insulin inhibits liver expression of the CCAAT/enhancerbinding protein beta. Diabetes 44, 267-271
164. Sekine, O. et al. (2002) Insulin activates CCAAT/ enhancer binding proteins and proinflammatorygene expression through the phosphatidylinositol 3-kinase pathway in vascular smooth muscle cells. Journal of Biological Chemistry 277, 36631-36639
165. Guo, S. et al. (2001) Insulin suppresses transactivation by CAAT/enhancer-binding proteins beta (C/EBPbeta). Signaling to p300/ CREB-binding protein by protein kinase B disrupts interaction with the major activation domain of C/EBPbeta. Journal of Biological Chemistry 276, 8516-8523
166. Grimm, S.L. et al. (2002) Disruption of steroid and prolactin receptor patterning in the mammary gland correlates with a block in lobuloalveolar development. Molecular Endocrinology 16, 2675-2691 (Pubitemid 36020650)
167. Nolten, L.A. et al. (1994) Expression of the insulin-like growth factor I gene is stimulated by the liver-enriched transcription factors C/EBP alpha and LAP. Molecular Endocrinology 8, 1636-1645
168. Umayahara, Y. et al. (2002) Protein kinase Cdependent, CCAAT/enhancer-binding protein beta-mediated expression of insulin-like growth factor I gene. Journal of Biological Chemistry 277, 15261-15270 (Pubitemid 34967786)
169. Umayahara, Y. et al. (1999) CCAAT/enhancer-binding protein delta is a critical regulator of insulin-like growth factor-I gene transcription in osteoblasts. Journal of Biological Chemistry 274, 10609-10617
170. McCarthy, T.L. et al. (2000) Time- and dose-related interactions between glucocorticoid and cyclic adenosine 30,50-monophosphate on CCAAT/enhancer- binding proteindependent insulin-like growth factor I expression by osteoblasts. Endocrinology 141, 127-137 (Pubitemid 32260351)
171. Nerlov, C. (2007) The C/EBP family of transcription factors: a paradigm for interaction between gene expression and proliferation control. Trends in Cell Biology 17, 318-324
172. Brennan, P., Donev, R. and Hewamana, S. (2008) Targeting transcription factors for therapeutic benefit. Molecular Biosystems 4, 909-919
173. Minucci, S. and Pelicci, P.G. (2006) Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer. Nature Reviews. Cancer 6, 38-51 (Pubitemid 43054973)
174. Liu, X. et al. (2008) The structural basis of protein acetylation by the p300/CBP transcriptional coactivator. Nature 451, 846-850 (Pubitemid 351253165)
175. Zheng, Y. et al. (2004) Selective HAT inhibitors as mechanistic tools for protein acetylation. Methods in Enzymology 376, 188-199 (Pubitemid 38200179)
176. Kohno, M. and Pouyssegur, J. (2006) Targeting the ERK signaling pathway in cancer therapy. Annals of Medicine 38, 200-211 (Pubitemid 43675585)
177. Yuan, T.L. and Cantley, L.C. (2008) PI3K pathway alterations in cancer: variations on a theme. Oncogene 27, 5497-5510
178. Gilmore, T.D. and Herscovitch, M. (2006) Inhibitors of NF-kappaB signaling: 785 and counting. Oncogene 25, 6887-6899 (Pubitemid 44657858)
179. Dey, A., Verma, C.S. and Lane, D.P. (2008) Updates on p53: modulation of p53 degradation as a therapeutic approach. British Journal of Cancer 98, 4-8
180. Mees, C., Nemunaitis, J. and Senzer, N. (2009) Transcription factors: their potential as targets for an individualized therapeutic approach to cancer. Cancer Gene Therapy 16, 103-112
181. Rizzo, P. et al. (2008) Rational targeting of Notch signaling in cancer. Oncogene 27, 5124-5131
182. Rishi, V. et al. (2005) A high-throughput fluorescence-anisotropy screen that identifies small molecule inhibitors of the DNA binding of B-ZIP transcription factors. Analytical Biochemistry 340, 259-271 (Pubitemid 40544865)
183. Turkson, J. et al. (2001) Phosphotyrosyl peptides block Stat3-mediated DNA binding activity, gene regulation, and cell transformation. Journal of Biological Chemistry 276, 45443-45455
184. Berg, T. et al. (2002) Small-molecule antagonists of Myc/Max dimerization inhibit Myc-induced transformation of chicken embryo fibroblasts. Proceedings of the National Academy of Sciences of the United States of America 99, 3830-3835 (Pubitemid 34252191)
185. Vassilev, L.T. et al. (2004) In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science 303, 844-848 (Pubitemid 38174664)
186. Efeyan, A. et al. (2007) Induction of p53-dependent senescence by the MDM2 antagonist nutlin-3a in mouse cells of fibroblast origin. Cancer Research 67, 7350-7357 (Pubitemid 47206565)
187. Olenyuk, B.Z. et al. (2004) Inhibition of vascular endothelial growth factor with a sequence-specific hypoxia response element antagonist. Proceedings of the National Academy of Sciences of the United States of America 101, 16768-16773 (Pubitemid 39601313)
188. Kozak, M. (1991) An analysis of vertebrate mRNA sequences: intimations of translational control. Journal of Cell Biology 115, 887-903
189. Raught, B. et al. (1996) Expression of a translationally regulated, dominant-negativeCCAAT/enhancer-binding protein beta isoform and up-regulation of the eukaryotic translation initiation factor 2alpha are correlated with neoplastic transformation of mammary epithelial cells. Cancer Research 56, 4382-4386 (Pubitemid 26330444)
190. Lincoln, A.J. et al. (1998) Inhibition of CCAAT/ enhancer-binding protein alpha and beta translation by upstream open reading frames. Journal of Biological Chemistry 273, 9552-9560 (Pubitemid 28183041)
191. Li, Y. et al. (2008) Differential control of the CCAAT/enhancer-binding protein beta (C/ EBPbeta) products liver-enriched transcriptional activating protein (LAP) and liver-enriched transcriptional inhibitory protein (LIP) and the regulation of gene expression during the response to endoplasmic reticulum stress. Journal of Biological Chemistry 283, 22443-22456
192. Sterneck, E., Tessarollo, L. and Johnson, P.F. (1997) An essential role for C/EBPbeta in female reproduction. Genes and Development 11, 2153-2162 (Pubitemid 27387967)
193. Millward, C.A. et al. (2007) Mice with a deletion in the gene for CCAAT/enhancer-binding protein beta are protected against diet-induced obesity. Diabetes 56, 161-167
194. Carmona, M.C. et al. (2005) Defective thermoregulation, impaired lipid metabolism, but preserved adrenergic induction of gene expression in brown fat of mice lacking C/EBPbeta. Biochemistry Journal 389, 47-56
195. Croniger, C.M. et al. (2001) Mice with a deletion in the gene for CCAAT/enhancer-binding protein beta have an attenuated response to cAMP and impaired carbohydrate metabolism. Journal of Biological Chemistry 276, 629-638 (Pubitemid 32050359)
196. Liu, S. et al. (1999) Hypoglycemia and impaired hepatic glucose production in mice with a deletion of the C/EBPbeta gene. Journal of Clinical Investigation 103, 207-213 (Pubitemid 29053138)
197. Greenbaum, L.E. et al. (1998) CCAAT enhancerbinding protein beta is required for normal hepatocyte proliferation in mice after partial hepatectomy. Journal of Clinical Investigation 102, 996-1007 (Pubitemid 28419244)
198. Tominaga, H. et al. (2008) CCAAT/Enhancer-binding Protein {beta} Promotes Osteoblast Differentiation by Enhancing Runx2 Activity with ATF4. Molecular Biology of the Cell 19, 5373-5386
199. Tanaka, T. et al. (1995) Targeted disruption of the NF-IL6 gene discloses its essential role in bacteria killing and tumor cytotoxicity by macrophages. Cell 80, 353-361
200. Screpanti, I. et al. (1995) Lymphoproliferative disorder and imbalanced T-helper response in C/EBP beta-deficient mice. EMBO Journal 14, 1932-1941
201. Tanaka, T. et al. (1997) Defective adipocyte differentiation in mice lacking the C/EBPbeta and/or C/EBPdelta gene. EMBO Journal 16, 7432-7443 (Pubitemid 28010503)